1. α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson's disease.
- Author
-
Zalon, Annie J., Quiriconi, Drew J., Pitcairn, Caleb, and Mazzulli, Joseph R.
- Subjects
- *
PARKINSON'S disease , *PROTEIN transport , *ENDOPLASMIC reticulum , *NEURODEGENERATION , *MESENCEPHALON - Abstract
Parkinson's disease (PD) is a common age-related neurodegenerative disorder characterized by the loss of dopaminergic neurons in the midbrain. A hallmark of both familial and sporadic PD is the presence of Lewy body inclusions composed mainly of aggregated α-synuclein (α-syn), a presynaptic protein encoded by the SNCA gene. The mechanisms driving the relationship between α-syn accumulation and neurodegeneration are not completely understood, although recent evidence indicates that multiple branches of the proteostasis pathway are simultaneously perturbed when α-syn aberrantly accumulates within neurons. Studies from patient-derived midbrain cultures that develop α-syn pathology through the endogenous expression of PD-causing mutations show that proteostasis disruption occurs at the level of synthesis/folding in the endoplasmic reticulum (ER), downstream ER-Golgi trafficking, and autophagic-lysosomal clearance. Here, we review the fundamentals of protein transport, highlighting the specific steps where α-syn accumulation may intervene and the downstream effects on proteostasis. Current therapeutic efforts are focused on targeting single pathways or proteins, but the multifaceted pathogenic role of α-syn throughout the proteostasis pathway suggests that manipulating several targets simultaneously will provide more effective disease-modifying therapies for PD and other synucleinopathies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF